Related Experiment Video
Updated: Aug 30, 2026

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
Published on: January 25, 2017
Human colon carcinomas constitutively express and shed type II IL-1 receptor, an IL-1 antagonist
Andrew W Stadnyk1, Moorix M W Yeung, Sen Rong Yan
1Department of Pediatrics, Dalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada.
Abstract:
We reported earlier that rat intestinal epithelial cells respond to helminth infection, to NSAID injury, and to detachment in vitro with expression of the IL-1RII. Now we have sought to determine whether human colon carcinoma cell lines express, or may be induced to express, this potent IL-1 antagonist. Using RT-PCR, the T84 and HT-29 cell lines constitutively expressed mRNA for the membrane-bound, but not the secreted variant of the receptor. The protein was detectable by immunohistochemistry and was estimated to be 70 kDa by western blotting. TNF treatment of T84 cells led to slightly increased levels of IL-1RII mRNA and to significant increases in soluble protein detected in culture supernatants. Treating T84 cells with inhibitory anti-IL-1RII antibodies led to heightened responsiveness to IL-1, measured as IL-8 production. Expression of the IL-1RII by human epithelial cells has implications in terms of the IL-1 agonist versus antagonist balance in the diseased intestines.
Insights
Human colon cells express the IL-1 receptor type II (IL-1RII), an IL-1 antagonist. This finding suggests IL-1RII plays a role in regulating inflammation in the human gut.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Rat intestinal cells express IL-1RII in response to helminth infection, NSAID injury, and detachment.
- The role of IL-1RII in human intestinal epithelial cells remains largely unexplored.
Purpose of the Study:
- To determine if human colon carcinoma cell lines express IL-1RII.
- To investigate if IL-1RII expression can be induced in these cells.
- To assess the functional significance of IL-1RII in human intestinal epithelial cells.
Main Methods:
- Reverse transcription-polymerase chain reaction (RT-PCR) to detect IL-1RII mRNA.
- Immunohistochemistry to detect IL-1RII protein.
- Western blotting to estimate protein size.
- Tumor Necrosis Factor (TNF) treatment to assess induction of IL-1RII.
- Treatment with inhibitory anti-IL-1RII antibodies to measure IL-8 production.
Main Results:
- T84 and HT-29 cell lines constitutively expressed mRNA for the membrane-bound IL-1RII.
- TNF treatment increased IL-1RII mRNA and soluble protein levels in T84 cells.
- Blocking IL-1RII function enhanced IL-1-induced IL-8 production in T84 cells.
Conclusions:
- Human colon carcinoma cell lines express the membrane-bound IL-1RII.
- IL-1RII expression can be modulated by TNF treatment.
- IL-1RII acts as an antagonist to IL-1, influencing IL-8 production in human intestinal epithelial cells, with implications for inflammatory gut diseases.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Renewal of Intestinal Stem Cells
Gastritis II: Pathophysiology
Type I Diabetes II: Pathophysiology

